Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Association Between Axillary Surgical Management and Survival in Patients with de novo Metastatic Breast Cancer.

Annals of surgical oncology·2026
Same author

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer.

Annals of surgical oncology·2026
Same author

European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO.

European radiology·2026
Same authorSame journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same author

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Related Experiment Video

Updated: Jun 11, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.0K

Practice-changing trials on breast cancer.

Youlia Kirova1, Jihane Bouziane1, Pierre Loap1

  • 1Department of Radiation Oncology, Institut Curie, Paris, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|September 28, 2024
PubMed
Summary
This summary is machine-generated.

New research explores hypofractionated radiotherapy for breast cancer, including ductal carcinoma in situ and post-mastectomy reconstruction. This approach aims to reduce toxicity while maintaining efficacy in various clinical scenarios.

Keywords:
Breast cancerCancer du seinHypofractionationHypofractionnementRadiotherapyRadiothérapie

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

29.6K

Related Experiment Videos

Last Updated: Jun 11, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.0K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

29.6K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Breast Cancer Treatment

Background:

  • Hypofractionated radiotherapy is emerging as a significant advancement in breast cancer management.
  • Recent clinical trials have investigated the efficacy and safety of reduced radiation fractionation schedules.
  • Key questions remain regarding the application of hypofractionation in specific patient populations and treatment scenarios.

Purpose of the Study:

  • To review and synthesize the latest evidence-based data on hypofractionated radiotherapy modalities.
  • To address the clinical applicability of hypofractionation in ductal carcinoma in situ (DCIS).
  • To evaluate hypofractionated whole breast radiotherapy with simultaneous integrated boost (SIB) and post-mastectomy reconstruction.
  • To assess the safety of hypofractionation in lymph node irradiation.

Main Methods:

  • Systematic review of recently presented and published clinical trial data.
  • Analysis of evidence pertaining to hypofractionated whole breast radiotherapy, SIB, and post-mastectomy irradiation.
  • Evaluation of toxicity profiles associated with hypofractionated lymph node irradiation.

Main Results:

  • Data suggests feasibility of hypofractionated whole breast radiotherapy for DCIS.
  • Hypofractionated radiotherapy with SIB demonstrates promising outcomes in select patient groups.
  • Evidence supports the safety and efficacy of hypofractionation in post-mastectomy settings with reconstruction.
  • Current data indicates that hypofractionation of lymph nodes can be achieved with acceptable toxicity.

Conclusions:

  • Hypofractionated radiotherapy represents a practice-changing modality in breast cancer treatment.
  • Evidence supports the expanded use of hypofractionation across various clinical scenarios, including DCIS, SIB, and post-mastectomy reconstruction.
  • Further research confirms the safety of hypofractionated lymph node irradiation, minimizing toxicity risks.